Published in AIDS Weekly, March 24th, 1997
The two companies have planned to develop and carry-out early stage clinical trials on two diagnostic tests for HIV: a quantitative viral load test and a full sequence based test. Both tests employ VGI's CLIP single-tube sequencing and stratified matrix testing methods, and run on VGI's OpenGene DNA sequencing platform.
Under the agreement, VGI adapts its CLIP and stratified matrix DNA testing methods to the quantitative viral analysis and DNA sequencing of CLS's HIV-1 samples using...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.